MindScape RetreatThread: New York Times validates ibogaine for treatment-resistant PTSD. Stanford research shows 68% remission rates. Worth reading if you're interested in emerging psychiatric treatments. https://twitter.com/i/web/status/2028112855371833615 #PTSD #VeteransHealth #MentalHealth
MindScape Retreat: Ibogaine Treatment Center (@ibogaineretreat) on X
🗞️ BREAKING: New York Times publishes comprehensive feature validating ibogaine for treatment-resistant PTSD. Citing Stanford 2024 research: 68% PTSD remission (vs 30% SSRIs). This is mainstream media recognition of ibogaine as serious clinical therapy, not fringe medicine. 🧵